Sprites
Sonntag, 19.05.2013Börsentäglich über 11.000 News von 442 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

COMPUGEN

WKN: 553001  ISIN: IL0010852080  Ticker-Symbol: CW9 
Aktie:
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
COMPUGEN Chart 1 Jahr
1-Woche-Intraday-Chart
COMPUGEN 1-Woche-Intraday-Chart
Aktuelle News zur COMPUGEN Aktie
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
08.05.-
26.04.1
10.04.1
01.04.1
13.03.1
26.02.60
TORONTO, ONTARIO -- (Marketwire) -- 02/26/13 -- Compugen Inc. today announced that it has been recognized with an HP Partner in Excellence Award for Canada Philanthropy at the 2013 HP Global Partner...
Mehr lesen zu:
Compugen Awarded HP Partner in Excellence Award
20.02.-
11.01.1
10.01.1
19.12.-
13.12.-
12.12.1
20.11.104
TORONTO, ONTARIO -- (Marketwire) -- 11/20/12 -- Compugen announced today that it has been selected as the winner in the Volume Licensing Partner of the Year and the Community Leadership Partner of...
Mehr lesen zu:
Compugen a Double Winner in the 2012 Microsoft Partner Network IMPACT Awards / Microsoft Canada Inc recognizes achievements of leading Canadian technology partners
14.11.82
Compugen Ltd. (NASDAQ: CGEN) today announced that its President and Chief Executive Officer, Dr. Anat Cohen-Dayag, will be presenting at the Jefferies 2012 Global Healthcare...
Mehr lesen zu:
Compugen to Present at Jefferies 2012 Global Healthcare Conference
18.09.54
TORONTO, ONTARIO -- (Marketwire) -- 09/18/12 -- Compugen Inc., Canada's largest IT solutions and services provider, is pleased to announce major peer recognition at 2012 Channel Elite Awards ceremony...
Mehr lesen zu:
Compugen Wins Gold and Silver at Channel Elite Awards / Datacentre Rebuild wins Gold in Enterprise Category; Desktop Virtualization Solution wins Silver in Mid-Market Category
10.09.46
Suggested mode of action for CGEN-15001 directly impacts key pathogenic aspects of autoimmune disease Results from pre-clinical studies for CGEN-15001 immune...
Mehr lesen zu:
Compugen Drug Candidate Demonstrates Attenuation of Autoimmunity and Reestablishment of Immune Balance
24.07.24
TORONTO, ONTARIO -- (Marketwire) -- 07/24/12 -- Canadian IT solutions provider Compugen Inc. today announced the completion of its one millionth service call. Service calls involve on-site visits by...
Mehr lesen zu:
Another Compugen Milestone: One Millionth Service Call Completed
25.06.111
BERLIN (dpa-AFX) - Merck Serono, a division of Merck, Darmstadt, Germany, and Compugen Ltd. (CGEN) announced the joint establishment of Neviah Genomics, a novel start-up company focused...
Mehr lesen zu:
Merck Serono, Compugen To Establish Neviah Genomics
25.06.168
Genf Und Tel Aviv, Israel (ots/PRNewswire) - - Neviah Genomic soll sich auf die Entdeckung und Entwicklung neuartiger Biomarker für Arzneimitteltoxizität konzentrieren - Compugen...
Mehr lesen zu:
Compugen und Merck Serono Ventures gründen neues Biomarker-Unternehmen Neviah Genomics
25.06.50
Neviah Genomic Ltd. to focus on the discovery and development of novel biomarkers for drug toxicity Compugen to utilize its predictive discovery technologies...
Mehr lesen zu:
Compugen and Merck Serono Ventures to Jointly Establish New Biomarker Company Neviah Genomics Ltd.
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
Aufklappen
Schliessen